Neuro-Oncology Program

Neuro-Oncology is the study and treatment of cancerous and non-cancerous tumors in the brain and spinal cord. Children’s Neuro-Oncology Program brings together a multidisciplinary team to care for patients with brain and spinal cord tumors. Our specialty team includes subspecialty physicians, neuropsychologists, clinical psychologists, nurse practitioners, social workers, and research scientists. We provide state-of-the-art diagnosis and treatment for brain tumors while caring for every child's emotional and psychological health.

Find Us

Why Families Choose Us

A Comprehensive Approach to Care

The Neuro-Oncology Specialty team brings together pediatric specialists from other medical specialties to give your child the best care possible. Your care team may include:

  • Neuro-Oncology
  • Neurosurgery
  • Neuropsychology
  • Endocrinology
  • Neurology
  • Radiation Oncology
  • Ophthalmology
  • Rehabilitation Medicine
  • Neuroradiologists

Sub-specialty Experts in Pediatric Neuro-oncology

  • Our neuro-oncologists lead the Neuro-Oncology Program, coordinate individual patient care, serve as principal investigators for a variety of clinical trials and manage the team to ensure expert care.
  • Children's Hospital Oakland is nationally recognized for the most talented, well trained and compassionate neurosurgeons in the country.
  • Our team values the important contributions of our clinical psychologists, neuropsychologists, and social workers. They assist patients and their families navigate the challenges of treatment as well as provide assessments and interventions to ensure optimal academic success and overall quality of life.

A Variety of Treatment Options

  • The Oncology Program is a member of the Children's Oncology Group (COG) which allows access to a variety of clinical trials being offered to children and adolescents with a brain or spinal cord tumors.
  • The Neuro-Oncology Program is one of approximately 40 centers worldwide that participate in the Head Start Consortium for Pediatric Brain Tumors. Head Start studies focus on improving the cure rate and quality of survival for newly-diagnosed young children with the most common type of malignant brain tumor. As a member of the Head Start Consortium, we can offer innovative therapies that substitute intensive chemotherapy and peripheral blood stem cell rescue in place of radiation therapy, in the hope that this treatment will decrease the long-term consequences of brain tumor treatment.
  • The Neuro-Oncology program at BCHO is also a charter member of the Pacific Pediatric Neuro-Oncology Consortium (PNOC), a network of 15 children’s hospitals nationally that conduct clinical trials of new therapies for children with brain tumors. PNOC’s goal is to improve outcomes by translating the latest findings in cancer biology into better treatments for these children.